WHY YOU NEED US
Turn Innovation
Into Value
We connect investors with high-quality deep tech opportunities. Each venture we build is supported by validated technology, strong teams, and scalable business models, designed to deliver both impact and return.
OUR PROCESS
SOURCE & VALIDATE
We identify and shape ventures emerging from top European research institutions working at the frontier of AI-driven autonomy for data, energy, industry, and healthcare.
Each opportunity is validated through our structured process, integrating technical readiness, IP strength, and early market validation to ensure only credible, scalable projects enter our portfolio.
Here's How We Help Investors
Access to Frontier Innovation
Invest in companies built around AI-driven autonomy for data, energy, industry, and healthcare — where breakthrough science meets clear market demand.
De-Risked Early Stage Ventures
Each company is validated technically and commercially before external funding, following a proven venture-building process from TRL 4 to TRL 8.
Integrated R&D Fundraising
We combine research capability with capital strategy and market access, creating ventures with robust tech, strong teams, and clear investment logic.
High Leverage Via Co-Investment
Our blended model aligns private investment with EU and national non-dilutive funding, improving capital efficiency and maximizing potential ROI.
OUR PORTFOLIO
Innovation You
Can Invest In
Explore a portfolio of pioneering ventures built at the intersection of science and strategy. Each company blends breakthrough research with commercial strength, delivering scalable technologies that redefine industries and create tangible impact.
MedTech
The Power of Precision Medicine.
Year Founded
2028
N/A
Amount Raised
Quantum
Shaping the Quantum Future.
Year Founded
2029
N/A
Amount Raised
Health Tech
Advancing Mental Health.
Year Founded
2019
Raising €1m
Amount Raised
Health Tech
AI-Powered Digital Therapeutics.
Year Founded
2025
Raising €500k
Amount Raised
Health
Franchising Brain Checkups.
Year Founded
2019
N/A
Amount Raised
MedTech
Making Biomedicine Affordable.
Year Founded
2028
N/A
Amount Raised
BioTech
Target, Deliver, Cure.
Year Founded
2023
Raised €2.3m
Amount Raised
Clean Tech
Revolutionising Compact Cooling.
Year Founded
TBC
N/A
Amount Raised
MedTech
Revolutionising How We Treat Cancer.
Year Founded
2030
N/A
Amount Raised
FAQs For Investors
We create and accelerate deep-tech ventures applying AI-driven autonomy to solve complex challenges in data, energy, industry, and healthcare. These companies emerge from partnerships with leading European research institutions and are structured for scalability and international growth.
Each venture progresses through defined KPIs covering product, business, and funding milestones. We manage R&D integration, MVP development, and early customer validation — so by the time an investor joins, the company has proven technology, a go-to-market plan, and a clear funding roadmap.
Our model has already supported over 30+ deep-tech startups across Europe, helping them raise more than €18 million in private investment and €5 million in public grants. Participating ventures have achieved nearly 100% KPI completion, validated technologies across four major sectors, created 40 new jobs, and increased their valuations by an average of €2 million each. These results demonstrate the effectiveness of our KPI-driven, co-development approach in transforming scientific excellence into investable companies.
Our ventures benefit from hybrid financing structures that merge private capital with EU or national innovation funding. This blended model de-risks early-stage investment while accelerating growth and increasing overall capital efficiency.
We begin with an introductory discussion to align with your investment thesis and sector focus. From there, we provide access to our venture pipeline, co-investment opportunities, and structured engagement models that fit your risk appetite and return expectations.